MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis by Bhatnagar, G et al.
MRI texture analysis parameters of contrast-
enhanced T1-weighted images of Crohn’s
disease differ according to the presence or
absence of histological markers of hypoxia and
angiogenesis
Gauraang Bhatnagar,1 Jesica Makanyanga,1 Balaji Ganeshan,2 Ashley Groves,2
Manuel Rodriguez-Justo,3 Steve Halligan,1 Stuart A. Taylor1
1Centre for Medical Imaging, University College London, 250 Euston Road, London NW1 2BU, UK
2Institute of Nuclear Medicine, University College London, London, UK
3Histopathology Department, University College London Hospitals, London, UK
Abstract
Purpose: To investigate if texture analysis parameters of
contrast-enhanced MRI differ according to the presence
of histological markers of hypoxia and angiogenesis in
Crohn’s disease (CD).
Methods: Seven CD patients (mean age 38 (19–75), 3
male)) undergoing ileal resection underwent 3T MR
enterography including axial ultrafast spoiled gradient-
echo T1 post IV gadolinium chelate. Regions of interest
were placed in bowel destined for resection and regis-
tered to trans-mural histological sections (n = 28 across
7 bowel sections) via MRI of the resected specimen.
Microvessel density (MVD) and staining for markers of
hypoxia (HIF 1a) and angiogenesis (VEGF) were
performed. Texture analysis features were derived utiliz-
ing an image filtration-histogram technique at spatial
scaling factor (SSF) 0–6 mm, including mean, standard
deviation, mean of positive pixels, entropy, kurtosis and
skewness and compared according to the presence or
absence of histological markers of hypoxia/angiogenesis
using Mann–Whitney U/Kruskal–Wallis tests and with
the log of MVD using simple linear regression.
Results: Mean, standard deviation and mean of positive
pixels were significantly lower in sections expressing
VEGF. For example at SSF 6 mm, median (inter-
quartile range) of mean, standard deviation and mean
of positive pixels in those with VEGF expression were
150.1 (134.7), 132.4 (49.2) and 184.0 (91.4) vs. 362.5
(150.2), 216.3 (100.1) and 416.6 (80.0) in those without
(p = 0.001, p = 0.004 and p = 0.001), respectively.
There was a significant association between skewness
and MVD (ratio 1.97 (1.15–3.41)) at SSF = 2 mm.
Conclusions: Contrast-enhanced MRI texture analysis
features significantly differ according to the presence or
absence of histological markers of hypoxia and angio-
genesis in CD.
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Abnormally increased neoangiogenesis is a histopatho-
logical hallmark of Crohn’s disease (CD) [1–3]. Increased
hypoxia-inducible factor 1a (HIF 1a) and vascular
endothelial growth factor (VEGF) expression is fre-
quently present in Crohn’s affected bowel [1, 4, 5], along
with increased mucosal and submucosal microvessel
density (MVD) [2]. While the drivers of neoangiogenesis
are complex, an increasing body of evidence suggests that
chronic inflammation is angiogenesis dependent [1]. This
vasculopathy has been targeted by new therapeutics such
as Natalizumab, an a4-integrin blocking monoclonal
antibody, recently approved to treat CD [6–8]. Non-in-
vasive imaging methods that quantify angiogenesis in
CD could therefore have immediate diagnostic utility,
which could guide therapy.
Magnetic resonance enterography (MRE) is used
frequently to assess CD. Disease activity is associated
with increased mural thickness [9–11] and T2 signal
intensity [11, 12], but also with increased contrast-en-
hanced mural signal intensity [9–12]. Contrast enhance-
ment kinetics in CD are however complex and related to
both MVD and disease chronicity [12–14] as well as
inflammation. It is intuitive therefore that the mural
signal pattern following IV contrast administration likely
reflects underlying angiogenesis within the bowel wall.
Interrogating this signal beyond simple mean intensity
could therefore provide new insights regarding the
underlying vasculopathy in CD.
Textural analysis (TA) is a post-processing technique
that can be applied to cross-sectional data to facilitate
analysis of heterogeneity within selected image regions
[15]. The filtration-histogram technique is a commonly
employed approach whereby image filtration extracts
features of different sizes which allows the histogram
distribution of grey-scale levels and/or pixel intensity on
computed tomography (CT) and magnetic resonance
imaging (MRI) to be quantified subsequently [16]. These
features may reflect underlying tissue structure, at least
in part. TA has been applied successfully to cross-sec-
tional imaging of cancer [17], particularly to investigate
underlying tumour vascularity. For example, Ganeshan
et al. demonstrated that TA parameters derived from
contrast-enhanced CT images may be imaging
biomarkers for tumour hypoxia and angiogenesis in non-
small-cell lung cancer (NSCLC) [18]. It is therefore
possible that TA of contrast-enhanced MRI images
could phenotype CD vasculopathy.
The purpose of this prospective study was to inves-
tigate any signiﬁcant differences between metrics ob-
tained by texture analyses of contrast-enhanced MRE
sequences (MRTA) in adult patients with small bowel
CD according to the presence of histological markers of
hypoxia and angiogenesis obtained from the same loca-
tion.
Materials and methods
Study population
The local research ethics committee approved this
prospective study and written informed consent was
obtained from all participants. Between January 2012
and September 2014, consecutive patients with proven
CD (based on standard clinical, endoscopic and histo-
logical criteria) and scheduled to undergo surgical
resection of diseased small bowel within 3 months were
invited to undergo pre-operative MRE.
Consenting patients were excluded from the current
study if they underwent MRI on an MRI scanner other
than the speciﬁc 3 Tesla (T) machine earmarked for this
study (see below) (n = 6), were under 16 years of age
(n = 0), were pregnant (n = 0), had contraindications
to MRI (such as severe claustrophobia; n = 1), or had a
pacemaker/metallic implant (n = 0). Patients were also
excluded if post contrast T1 axial sequences were not
performed (n = 2) or if this sequence was affected by
significant artefact precluding further analysis (n = 1).
For this initial pilot study, patients scanned on a 1.5 T
platform were excluded as post contrast images were
non-isotropic (unlike at 3 T) which could affect textural
analysis. Furthermore, we wanted to avoid the potential
confounder of magnet strength on post contrast
enhancement T1 signal. Similarly for this pilot, patients
were included if the time between MRI and surgery was
greater than 3 months due to unforeseen delays in sur-
gical intervention.
Overall 7 patients were eligible (mean age 36 years,
4F) for this study. Indications for elective small bowel
resection included obstructing ileal stricture (n = 4),
entero-enteric fistulation (n = 2) and entero-cutaneous
fistula (n = 1). The mean temporal interval between
MRI and surgery was 55 days (range 5–175).
The Montreal classiﬁcation and C-reactive protein
(CRP) were recorded for each patient up to 5 days prior
to surgery.
MRI imaging protocol
After a 4-h fast, patients ingested 1 L of 2% mannitol
solution over 40 min and were scanned in the prone
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position on a 3 T static magnet (Phillips Achieva 3.2.1.1,
Philips Achieva, Philips Healthcare, Best, The Nether-
lands) using the manufacturer’s body and spine array
coils following IV administration of 20 mg hyoscine
butylbromide (Buscopan, Boeringer-Ingelheim, Ingel-
heim, Germany).
The MRI sequence protocol is given in Table 1 and
included standard axial and coronal balanced turbo
field-echo (BTFE) and half-Fourier acquisition single-
shot turbo spin echo (HASTE) images. In addition, a
dynamic contrast-enhanced protocol was acquired using
an ultrafast gradient-echo T1 high-resolution isotropic
volume excitation (THRIVE) sequence. Specifically,
following intravenous administration of 18 mls
gadopentetate dimeglumine (Magnevist; Berlex Labora-
tories, Wayne, NJ) into an arm vein at 3 mL/s via power
injector (Sonic shot GX, Nemoto, Japan), coronal ima-
ges were acquired through the entire small bowel volume
(TR 2.3 ms TE 1.04 ms, image matrix 224 9 224, voxel
size 1.8 9 1.8 9 2 mm, 80 slices, flip angle 10, SENSE
factor 4) with 80 measurements every 3.3 s until 264 s.
Thereafter, a breath-hold axial image block was acquired
(image matrix 576 9 576, voxel size 2 9 2 9 2 mm, 140
slices, flip angle 10, SENSE factor 4) commencing 300 s
following intravenous contrast injection. This delayed
axial post contrast sequence was used for texture analy-
sis.
Image histological registration
The technique for matching sites of histological sampling
to pre-operative MRI followed that published previously
by Punwani et al. [13]. In brief, within 24 h of surgery, a
post-operative MRI scan of the resected specimen (pin-
ned to a board in its correct anatomical orientation) was
performed using a single-shot turbo spin-echo (SSTSE)
sequence in axial and coronal planes (TR 800 ms, TE
86 ms, matrix 256 9 195, slice thickness 4 mm).
The study coordinator, a researcher with 5 years’
experience of small bowel MRI, reviewed the pre-oper-
ative MRI images along with the operating surgeon so as
to locate the exact segment of bowel resected (using ﬁxed
anatomical landmarks such as the ileo-caecal valve
(ICV), site of any stricture/ﬁstula etc.) and then chose
one to ﬁve image sections (median, three) through the
resected bowel on the pre-operative MRI for histological
correlation. The sections were selected to encompass the
range of disease severity with the resected segment, based
on conventional MRI parameters, including bowel wall
thickness and T2 signal. Subsequently, the coordinator
carefully reviewed the resected specimen with the study
histopathologist (15 years of experience in GI
histopathology) in order to register selected histological
sections with reference to the both the corresponding
pre-operative MRI and post-operative specimen scan,
again with reference to ﬁxed anatomical landmarks [13].
Region of interest placement
The axial T1 post contrast (THRIVE) weighted images
were uploaded into proprietary software for textural
analysis (TexRAD, www.texrad.com, part of Feedback
Plc, Cambridge, UK) [16]. A radiologist ((GB) with
4 years of experience of MRE) unaware of all clinical
and histopathological data (other than the exact site of
sectioning) but aware of the study aims placed a single
free-hand region of interest (ROI) at each of the pre-
identified sections of histological sampling (Fig. 1). The
observer reviewed the complete MRE dataset at the time
of placing the ROI (OsiriX 64 bit Imaging software,
Pixmeo, Geneva, Switzerland) using all available se-
quences to locate the exact site of histopathological
sampling. The ROI was then replicated on the axial T1
post contrast sequence on the textural analysis software,
taking care to exclude any luminal or mesenteric tissue
but to include the full bowel wall regardless of
enhancement pattern.
Texture analysis
Textural analysis with a ﬁltration-histogram technique
was performed within the ROI using previously pub-
Table 1. 3 Tesla (T) magnetic resonance imaging (MRI) parameters
Coronal/axial balanced
steady-state
free precision
Coronal/axial
balanced steady-state
gradient echo with
and without fat saturation
Baseline volume
interpolated
gradient echo
Dynamic
contrast-enhanced
Axial post
contrast (300 s)
Field of view (mm) 400 9 340 9 198/375 9 295 9 319 400 9 400 9 171/380 9 235 9 344 390 9 390 9 164 400 9 400 9 164 400 9 261 9 280
No. of slices 36/64 34/69 82 80 140
Stacks 1/1 1/1 1 1 1
Repetition time (ms) 1200/1100 1200/1100 2.3 2.3 2.3
Echo time (ms) 80/80 80/80 1.13 1.04 1.04
Image matrix 400/384 528/512 576 9 576 224 9 224 576 9 576
Slice thickness (mm) 5/4 4/4 2 2 2
Averages 1 1 1 1 1
Flip angle 45/45 90/90 10 10 10
s, seconds; mm, millimetres; ms, milliseconds
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lished methodology [16]. Filtration extracts and enhances
texture features apparent at different sizes within ROIs,
before subsequent histogram analysis. Specifically, a
Laplacian of Gaussian spatial band-pass filter is em-
ployed to achieve in-plane filtration, within the ROI. The
derived series of images contains features highlighted at
different spatial scales, ranging from fine to coarse tex-
tures (SSF = 0–6 mm). Histogram quantification then
generates the following parameters: mean (average value
of the pixels within the ROI), standard deviation (SD,
width of the histogram or degree of variation/dispersion
from the average), skewness (symmetry of the distribu-
tion), mean of positive pixels (MPP, average of the pixel
values that are positive), kurtosis (distribution ‘‘pointi-
ness’’ or ‘‘sharpness’’) and entropy (with increasing
irregularity or complexity indicated by a higher entropy
value). A simulation study explaining what these texture
quantifiers mean in relation to image features is de-
scribed by Miles et al. [16].
Histopathological assessment
Histological analysis was performed by a specialist gas-
trointestinal pathologist (MR) with 15 years of experi-
ence, blind to the MRE ﬁndings or texture analysis.
Immunoperoxidase studies were performed on 4-lm-
thick parafﬁn-embedded sections of formalin-ﬁxed tissue
samples. The sections were incubated with antibodies for
vascular markers (CD31/CD34), VEGF and HIF1a.
Positive immunohistochemical staining for VEGF and
HIF1a was noted in epithelial cells/ﬁbroblasts and
leukocytes within the bowel wall. In addition to its
presence, the intensity of staining in leucocytes only was
graded using a 3-point scale: weak, moderate and strong.
Microvessels were counted in the most intensely vascu-
larized areas (‘‘hot spots’’) at 2009 magniﬁcation. Mean
values for vessel count density (MVD) were calculated as
the arithmetic mean of 3 counted hot spots.
Statistical analysis
The primary analysis was to search for any signiﬁcant
differences between each textural parameter and the
presence or absence of histological markers of hypoxia
(HIF1 alpha) and angiogenesis (VEGF). A secondary
analysis examined for any correlation between
microvessel density and textural parameters. All statis-
tical analyses employed SPSS Statistics version 22 (IBM,
New York, USA). A sample size calculation was not
undertaken. Each textural analysis parameter at each
ﬁlter level was compared according to the presence or
absence of HIF 1a and VEGF in both leucocytes and
epithelium/ﬁbroblasts for each histopathological section
using Mann–Whitney U and Kruskal–Wallis tests as
appropriate. To account for multiple comparisons, a p
value of <0.01 was taken to represent statistical signif-
icance.
MVD was measured on a continuous scale. This
variable was found to have a positively skewed distri-
bution, and was thus log transformed before linear
regression analysis. Results were expressed as ratios that
described the relative change in MVD for a given in-
crease in each textural parameter. As there were multiple
histological sections from each patient, robust standard
errors were employed within the regression analyses to
account for data clustering.
Fig. 1. Graphic
demonstrating placement of
texture region of interest
(ROI and TexRAD interface
at different specified SSFs.
The top row reflects the
DICOM image analysed
(left), the image pixels
highlighted by the 3 mm
SSF (middle) and a
magnified view of the ROI
placed on disease site
sampled histologically
(right). The bottom row
reflects the DICOM image
analysed (left), the image
pixels highlighted by the
6 mm SSF (middle) and a
magnified view of the ROI
placed on disease site
sampled histologically
(right).
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Any relationship between histological markers
(MVD, HIF and VEGF) was tested using Pearson’s
correlation coefﬁcient.
Results
Baseline clinical data
Demographic characteristics of the patient cohort are
shown in Table 2. The ROIs employed for MRTA con-
tained a mean of 858 pixels (range 247–1964).
Histological analysis of the microvasculature,
hypoxia and angiogenesis
Mean MVD was 42 (19–90). Using a normal upper limit
for MVD of 25 [2], 20 of 28 sections (71%) demonstrated
abnormal MVD. All 7 patients had a least one section
with MVD of greater than 25.
Epithelium/ﬁbroblast VEGF expression was positive
in 21 (75%) sections and leucocyte VEGF expression was
positive in 13 (46%) sections. Leucocyte VEGF expres-
sion was graded as 0 = 15 (54%), 1+ = 0(0%),
2+ = 2 (7%) and 3+ = 11 (39%).
Epithelium/ﬁbroblast HIF 1a expression was positive
in 15 (54%) sections and leucocyte HIF 1a expression in
12 (43%) sections. Leucocyte HIF 1a expression was
graded as 0 = 16 (57%), 1+ = 3 (10%), 2+ = 2 (7%)
and 3+ = 7 (25%).
MVD correlated positively with HIF 1a expression in
leucocytes (0.79, p = 0.001), VEGF expression in
epithelium/fibroblasts (0.52, p = 0.005) and VEGF
expression in leucocytes (0.73, p = 0.001). HIF 1a
expression correlated positively with VEGF expression in
leucocytes (0.93, p = 0.001).
MRTA parameters differ according to the
presence of histological markers of hypoxia and
angiogenesis
The complete range of values for all MRTA parameters
is shown in Table 3.
Regression analysis revealed a positive association
between skewness (SSF = 2 mm) and log-transformed
MVD (ratio 1.97 (3.41–1.15) p = 0.014) (Fig. 2).
At the pre-determined level of statistical signiﬁcance,
the mean of ﬁltered pixel intensity was signiﬁcantly lower
in sections expressing VEGF in epithelium/ﬁbroblasts
than in those without expression at all ﬁlter levels other
than SSF = 2 mm (p = 0.004 to 0.001) (Table 4; Fig. 3).
Similarly, MPP was signiﬁcantly lower in sections
expressing VEGF in epithelium/ﬁbroblasts than in those
without expression at all ﬁlter levels (p = 0.007 to 0.001)
(Table 4; Fig. 4).
Standard deviation (SD) was signiﬁcantly lower in
sections expressing VEGF in epithelium/ﬁbroblasts at
SSF = 3 and 6 (p = 0.01, 0.004) (Table 4; Fig. 5).T
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No other signiﬁcant differences in MRTA parameters
were found according to the presence or absence of HIF
1a or VEGF.
Discussion
This study demonstrates that several parameters derived
from contrast-enhanced MRTA (mean, SD, MPP and
skewness) differ signiﬁcantly according to the presence or
absence of histological markers of angiogenesis (MVD
and VEGF expression) in CD.
Neoangiogenesis is well described in CD. While
inﬂammation is clearly related to angiogenesis, several
alternate processes (such as cell-to-extracellular matrix
interaction, vessel wall maturation and basal lamina
modiﬁcations) are implicated in new vessel development
[19]. It is believed that HIF 1a is one of the primary
initial stimulants for the pathway [19]. The downstream
processes are largely impacted by the ability of leuko-
cytes to release proangiogenic factors such as VEGF and
tumour necrosis factor-a (TNF-a) [19]. VEGF in par-
ticular is very well characterized as a regulator of
angiogenesis and stimulates a sustained angiogenic cas-
cade that is implicated in the pathophysiology of many
chronic inflammatory diseases such as rheumatoid
arthritis, psoriasis and atherosclerosis [20, 21]. In CD,
MVD and VEGF levels are significantly higher in ac-
Table 3. Mean and range of values of magnetic resonance textural analysis parameters
SSF Mean (range) SD (range) Entropy (range) MPP (range) Skewness (range) Kurtosis (range)
0 285.8 (112.0–1102.0) 62.0 (27.4–207.6) 5.0 (4.4–5.7) 285.8 (112.0–1102) -0.64 (-1.5 to 0.0) 0.2 (-1.2 to 2.1)
2 71.0 (7.6–161.9) 135.7 (64.5–243) 5.7 (5.1–6.3) 139.1 (53.0–241.3) -0.1 (-0.6 to 0.7) 0.2 (-1.0 to 1.9)
3 119.0 (13.2–269.6) 169.1 (72.8–356.5) 5.8 (5.2–6.4) 192.4 (58.1–364.8) -0.2 (-0.8 to 0.8) -0.1 (-0.8 to 2.4)
4 159.3 (19.3–369.5) 181.1 (71.2–491.8) 5.8 (5.2–6.4) 227.5 (58.6–528.1) -0.3 (-1.1 to 0.6) -0.1 (-0.9 to 3.1)
5 191.3 (25.0–437.5) 183.7 (72.1–583.8) 5.7 (5.2–6.5) 251.0 (59.9–629.3) -0.4 (-1.3 to 0.4) -0.0 (-1.0 to 3.1)
6 216.1 (30.0–487.6) 185.4 (70.4–642) 5.7 (5.1–6.6) 271.0 (62.6–758.5) -0.5 (-1.3 to 0.6) 0.0 (-1.1 to 3.9)
0
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Fig. 2. Scatter plot demonstrating significantly positive cor-
relation between skewness and log-transformed microvessel
density (MVD) (SSF = 2 mm) (ratio 1.97 (p value = 0.014)).
Fig. 3. Box-and-whisker plot (minimum, inter-quartile range,
median and maximum) (SSF = 6 mm) demonstrating signifi-
cantly lower mean pixel intensity in sections with vascular
endothelial growth factor (VEGF) expression (n = 21) in the
epithelium/fibroblasts as opposed to those without VEGF
expression (n = 7).
Table 4. Mean pixel intensity, standard deviation of pixel intensity and mean of positive pixels according to vascular endothelial growth factor
(VEGF) expression and filter levels (*Mann–Whitney p = 0.01 taken to be significant)
SSF = 0 SSF = 2 SSF = 3 SSF = 4 SSF = 5 SSF = 6
Mean
VEGF Present (n = 21) 210.5 (85.5) 59.5 (31.1) 96.7 (62.1) 116.2 (75.8) 122.2 (108.0) 150.1 (134.7)
VEGF Absent (n = 7) 298.0 (41.4) 100.9 (38.5) 170.3 (50.1) 243.3 (63.5) 306.8 (11.8) 362.5 (150.2)
p value* 0.003 0.014 0.004 0.003 0.001 0.001
SD
VEGF Present (n = 21) 45.0 (23.5) 115.7 (50.0) 130.4 (51.7) 139.4 (51.5) 142.4 (42.2) 132.4 (49.2)
VEGF Absent (n = 7) 66.8 (39.0) 162.6 (39.9) 220.1 (59.0) 226.2 (56.9) 217.9 (82.3) 216.3 (100.1)
p value 0.036 0.023 0.01 0.02 0.012 0.004
MPP
VEGF Present (n = 21) 210.5 (85.5) 118.6 (51.9) 143.6 (58.9) 174.6 (57.4) 181.4 (69.5) 184.0 (91.4)
VEGF Absent (n = 7) 298.0 (41.4) 175.3 (17.5) 246.0 (51.6) 296.7 (74.0) 362.7 (150.2) 416.6 (80.0)
p value 0.003 0.007 0.003 0.004 0.002 0.001
n refers to the number of bowel segments
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tively inflamed mucosa than in non-inflamed mucosa or
mucosa from controls [2].
The current study found that mean (brightness of ob-
jects), MPP (brightness of highlighted objects) and SD
(variability in the brightness of objects) on post contrast
T1 sequences are lower in bowel expressing VEGF in
epithelium/ﬁbroblasts compared to bowel without such
expression [16]. It would be assumed that tissues with in-
creased vascularity will appear of higher signal on T1 post
contrast sequences onMRI. This study also demonstrated
a positive correlation between MVD and HIF 1a expres-
sion,MVDandVEGF expression, andHIF 1a andVEGF
expression. Therefore, we may postulate that hypoxia
secondary to reduced blood supply to Crohn’s affected
bowel stimulates HIF 1a, thereby increasing VEGF
expression, resulting in an increase in the number of
microvessels. Work in oncology has demonstrated that
neoangiogenic vessels are irregular and function poorly,
resulting in inefficient vascular supply that may explain
why segments with neoangiogenesis have a reduced and
less varied proportion of bright objects [22]. Although
there is an association between active inflammation and
increased signal intensity on post contrast T1 sequences
[23], it is also known that a negative correlation exists
between the slope of enhancement and MVD on dynamic
contrast-enhanced MRI [24]. It is therefore evident that
post contrast mural T1 signal heterogeneity in CD is
dependent on the complex interplay between inflamma-
tion and angiogenesis.
The ﬁndings of the current study parallel similar work
using TA in cancer. For example, a negative correlation
between SD and MPP, and angiogenic burden (measured
by antibodies to CD34) has been demonstrated in
NSCLC lung cancer [18]. Miles et al. proposed an
algorithm employing a specific threshold of MPP
(<17.5) to differentiate between KRAS wild type and
mutants, the latter associated with hypoxia and angio-
genesis [25, 26]. Our findings are consistent with these
studies and indicate that lower values of these texture
parameters are associated with the presence of angio-
genesis in inflammatory diseases as well as malignancy.
Additionally, the findings appear consistent across dif-
ferent imaging modalities such as contrast-enhanced CT
and positron emission tomography–CT (PET–CT) [18,
27] adding weight to the assertion that these TA
parameters are indeed direct markers of angiogenesis.
We also demonstrated a signiﬁcantly positive corre-
lation between skewness and MVD (SSF = 2 mm).
Positive skewness occurs when there are a larger pro-
portion of bright objects within the ROI and again our
ﬁndings mirror those from oncology where there is a
positive association between skewness (on PET–CT) and
angiogenesis in colorectal cancer [27].
In contradistinction to our ﬁndings relating MRTA
parameters to MVD and VEGF, we found no relation-
ship between MRTA and HIF 1a expression.
Most of our statistically signiﬁcant observations were
evident at multiple SSF levels, especially those >2 mm.
Higher SSF levels highlight larger objects within the ROI,
which may emphasize more biologically relevant hetero-
geneityandminimize the impactof intrinsic imagenoise [16].
Our study has limitations. The sample size is small
(necessarily so because the proportion of CD patients who
come to resection is small) and, for at least some of the
recruits, the temporal interval between MRI and surgery
was relatively long. However, our prime aim was to test if
the observations linking MRTA parameters to angiogen-
esis in cancer studies held true for CD. In this regard, this
initial exploratory study was successful, although at best
our ﬁndings are observational. Although using full-thick-
ness histological sections in postsurgical specimens is
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Fig. 4. Box-and-whisker plot (minimum, inter-quartile range,
median and maximum) (SSF = 3 mm) demonstrating signifi-
cantly lower mean of positive pixels (MPP) in sections with
vascular endothelial growth factor (VEGF) expression
(n = 21) in the epithelium/fibroblasts as opposed to those
without VEGF expression (n = 7).
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Fig. 5. Box-and-whisker plot (minimum, inter-quartile range,
median and maximum) (SSF = 6 mm) demonstrating signifi-
cantly lower standard deviation (SD) of pixel intensity in
sections with vascular endothelial growth factor (VEGF)
expression (n = 21) in the epithelium/fibroblasts as opposed
to those without VEGF expression (n = 7).
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arguably the strongest reference standard for this type of
work, there is a risk of selection bias as, by deﬁnition, pa-
tients have disease sufﬁciently advanced and/or compli-
cated tomerit surgical resection. ROI placement in normal
bowel is technically challenging, but we placed ROIs in
thickened abnormal bowel, which is easier. We used pre-
viously successful techniques to register imaging and his-
tological sampling sites as exactly as possible. MRTAwith
TexRad is most reliable when employing isotropic voxels,
which limited our analysis to axial T1 post contrast-en-
hanced images only, whichwere acquired at 300 s. This is a
time point beyond that usually acquired as part of normal
clinical practice and may limit the clinical applicability of
our ﬁndings. However, it could be argued that using such
delayed images (when the contrast pool approaches near
equilibrium between blood and tissue) our data better re-
ﬂect intrinsic mural vascularity as opposed to large vessel
blood supply (which exerts greater inﬂuence at earlier time
points post contrast). Furthermore, Rimola et al. have re-
cently described that the use of post contrast imaging at
7 min may help distinguish between ﬁbrosis and inﬂam-
mation. It would be interesting to test if our observations
hold true at this later time point [28]. Like other workers
investigating MRTA [29, 30], we did not normalize our
post contrast T1 signal intensity values across patients,
which could limit inferences regardingmean, SD andMPP
values. However, we acquired our data from a single 3T
MRI platformwith similar gain factor between patients, to
mitigate against a lack of normalization. That our findings
mirror those published using other imaging platforms such
as CT is reassuring that our results are not spurious. As
noted above, our data are at best observational and logical
next steps would be to investigate TA parameters before
and after treatment to see if they could act as biomarkers
for therapeutic response.
Conclusion
Contrast-enhanced MRTA features differ signiﬁcantly
between CD bowel exhibiting histological markers of
angiogenesis compared with bowel that does not.
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